Search results for "Drug Interactions"
Improving HCV treatment and screening in primary care
Amid global calls to eliminate viral hepatitis, efforts are underway to screen asymptomatic adults for hepatitis C and overcome barriers to treatment.
https://immattersacp.org/archives/2022/01/improving-hcv-treatment-and-screening-in-primary-care.htm
1 Jan 2022
New COVID-19-related guidance on CPR, chest imaging, hydroxychloroquine
Medical societies addressed appropriate resuscitation and chest imaging practices for patients with COVID-19, issued guidelines on treatment and management, and warned about arrhythmia risks with hydroxychloroquine and azithromycin.
https://immattersacp.org/weekly/archives/2020/04/14/1.htm
14 Apr 2020
Optimism on outpatient COVID-19 treatment options
ACP and Annals of Internal Medicine's seventh forum on COVID-19 tackled new and existing treatments amid a rising number of cases from the omicron variant.
https://immattersacp.org/archives/2022/01/optimism-on-outpatient-covid-19-treatment-options.htm
1 Jan 2022
Drug interaction risks appear common among older patients being treated for epilepsy
Factors predicting higher drug interaction risk included having one or more comorbid condition versus zero comorbidities, having four or more comorbid conditions versus zero comorbidities, being eligible for the Medicare Part D Low-Income Subsidy, and not living in the northeastern U.S.
https://immattersacp.org/weekly/archives/2018/02/13/4.htm
13 Feb 2018
Managing HIV with testing, prevention
Antiretroviral therapy has made an impact in treating HIV, but preexposure prophylaxis has created a huge opportunity in preventing infection, with internists poised to play a role.
https://immattersacp.org/archives/2020/03/managing-hiv-with-testing-prevention.htm
1 Mar 2020
MKSAP Quiz: 3-year history of dyspnea, cough
A 69-year-old man is evaluated for a three-year history of dyspnea and chronic productive cough. He was diagnosed with chronic obstructive pulmonary disease (COPD) two years ago and has been treated for three exacerbations in the past year. He is taking tiotropium, fluticasone/salmeterol, and albuterol inhalers. Which long-term treatment is most likely to reduce exacerbations?
https://immattersacp.org/weekly/archives/2019/03/05/3.htm
5 Mar 2019
Lessons from an outbreak
This issue also covers preexposure prophylaxis for HIV, adult survivors of congenital heart disease, and age-friendly geriatric care.
https://immattersacp.org/archives/2020/03/lessons-from-an-outbreak.htm
1 Mar 2020
CDC expands recommendations for latent tuberculosis treatment
Expanded recommendations specifically include use in children, in persons co-infected with HIV/AIDS and latent tuberculosis, and by self-administration.
https://immattersacp.org/weekly/archives/2018/07/10/4.htm
10 Jul 2018
New options no panacea for depression
Internists can have the greatest impact by continuing to be the first point of contact, treating mild to moderate depression, and explaining what may be available if first-line options fall short.
https://immattersacp.org/archives/2019/09/new-options-no-panacea-for-depression.htm
1 Sep 2019
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://immattersacp.org/weekly/archives/2018/12/04/2.htm
4 Dec 2018